A recent issue of Pharmacotherapy1
contains an error regarding the duration of vincristine dosing
as a part of a CAV regimen. The article, referenced below,
listed the vincristine dose as 1.4 mg/m2
to be given on days 1-5 of the chemotherapy regimen.
In fact, vincristine should only be given on day 1 of the
regimen. The publisher is aware of this error, and plans to
print a correction on page 1144 of the September 2000 issue
(20:9).
1. Adams V. Adverse events associated with
chemotherapy for common cancers. Pharmacotherapy 2000;20(7):96-103S.
